68Ga-PSMA-11 and 18F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate

被引：8
|
作者：
Qiu, Shuang [1 ]
Dong, Aisheng [1 ]
Zhu, Yan [2 ]
Zuo, Changjing [1 ]
机构：
[1] Navy Med Univ, Changhai Hosp, Dept Nucl Med, 168 Changhai Rd, Shanghai 200433, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Pathol, Shanghai, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期
关键词：
prostatic ductal adenocarcinoma; PSMA; FDG; PET/CT;
D O I：
10.1097/RLU.0000000000004230
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Prostatic ductal adenocarcinoma is an uncommon variant of prostatic carcinoma with aggressive behavior and worse prognosis. We describe Ga-68-PSMA-11 and FDG PET/CT findings in a case of prostatic ductal adenocarcinoma with pelvic lymph node metastases. The majority of the prostate tumor and all the metastatic lesions showed no significant PSMA uptake but intense FDG uptake. The role of PSMA and FDG PET in the management of prostatic ductal adenocarcinoma needs to be investigated in a large number of patients.
引用
收藏
页码：836 / 838
页数：3
相关论文
共 50 条
  • [21] 68Ga-PSMA-11 PET/CT versus 68Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis
    Huang, Ruizhe
    Li, Yizhen
    Wu, Haowen
    Liu, Boyi
    Zhang, Xuanjun
    Zhang, Zhongxi
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] The Appearance of Sjogren Syndrome on 68Ga-PSMA-11 PET/CT
    Li, Rou
    Li, Danni
    Li, Xiao
    Zuo, Changjing
    Cheng, Chao
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (06) : 517 - 519
  • [23] The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma
    Randy Yeh
    Laurent Dercle
    Ishan Garg
    Zhen Jane Wang
    David M. Hough
    Ajit H. Goenka
    Abdominal Radiology, 2018, 43 : 415 - 434
  • [24] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [25] The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma
    Yeh, Randy
    Dercle, Laurent
    Garg, Ishan
    Wang, Zhen Jane
    Hough, David M.
    Goenka, Ajit H.
    ABDOMINAL RADIOLOGY, 2018, 43 (02) : 415 - 434
  • [26] Comparative Findings Between 68Ga-PSMA and 18F-FDG PET/CT for Hepatocellular Carcinoma
    Erhamamci, Seval
    Aslan, Nesrin
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2020, 29 (03) : 135 - 138
  • [27] Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients
    Leon Will
    Frederik L. Giesel
    Martin T. Freitag
    Anne K. Berger
    Walter Mier
    Klaus Kopka
    Stefan A. Koerber
    Hendrik Rathke
    Christophe Kremer
    Clemens Kratochwil
    Hans-Ulrich Kauczor
    Uwe Haberkorn
    Tim F. Weber
    Cancer Imaging, 17
  • [28] 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor
    Acar, Emine
    Kaya, Gamze Capa
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : 53 - 54
  • [29] Atypical Presentation of Liver Metastases of Prostate Cancer in 68Ga-PSMA-11 PET/CT
    Stanzel, Susanne
    Weitzer, Friedrich
    Janek, Elmar
    Plhak, Elisabeth
    Aigner, Reingard M.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1064 - 1065
  • [30] Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients
    Will, Leon
    Giesel, Frederik L.
    Freitag, Martin T.
    Berger, Anne K.
    Mier, Walter
    Kopka, Klaus
    Koerber, Stefan A.
    Rathke, Hendrik
    Kremer, Christophe
    Kratochwil, Clemens
    Kauczor, Hans-Ulrich
    Haberkorn, Uwe
    Weber, Tim F.
    CANCER IMAGING, 2017, 17
12345